2017 年至 2020 年，酒精性肝病死亡率上升，并在新冠疫情期间加速。
Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic.
机构信息
Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Department of Statistical Science, Duke University, Durham, North Carolina.
出版信息
Clin Gastroenterol Hepatol. 2022 Sep;20(9):2142-2144.e2. doi: 10.1016/j.cgh.2022.03.017. Epub 2022 Mar 19.
Alcohol consumption has risen substantially in the United States in the past 2 decades. Alcohol-associated liver disease (ALD) represents a greater inpatient financial burden than all other etiologies of cirrhosis combined and is now the leading indication for liver transplantation. A recent study reported that ALD mortality increased between 2006 and 2017. Since 2017, alcohol consumption has continued to rise, and more significantly during the COVID-19 pandemic. The aim of this research letter is to provide the most updated trends in ALD-related mortality in the United States and to quantify the rate of change of ALD-related mortality over time.
在过去的 20 年里，美国的酒精消费大幅上升。与酒精相关的肝脏疾病（ALD）比所有其他肝硬化病因的住院费用总和还要高，现在是肝移植的主要指征。最近的一项研究报告称，ALD 的死亡率在 2006 年至 2017 年间有所上升。自 2017 年以来，酒精消费持续上升，尤其是在 COVID-19 大流行期间。本研究快报的目的是提供美国与 ALD 相关的死亡率的最新趋势，并量化随着时间的推移，与 ALD 相关的死亡率的变化率。
Zotero 插件